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Abstract. In vivo measurement of photosensitizer concentrations may optimize clinical photodynamic therapy
(PDT). Fluorescence differential path-length spectroscopy (FDPS) is a non-invasive optical technique that has
been shown to accurately quantify the concentration of Foscan® in rat liver. As a next step towards clinical transla-
tion, the effect of two liposomal formulations of mTHPC, Fospeg® and Foslip®, on FDPS response was investigated.
Furthermore, FDPS was evaluated in target organs for head-and-neck PDT. Fifty-four healthy rats were intrave-
nously injected with one of the three formulations of mTHPC at 0.15 mgkg−1. FDPS was performed on liver, ton-
gue, and lip. The mTHPC concentrations estimated using FDPS were correlated with the results of the subsequent
harvested and chemically extracted organs. An excellent goodness of fit (R2) between FDPS and extraction
was found for all formulations in the liver (R2 ¼ 0.79). A much lower R2 between FDPS and extraction was
found in lip (R2 ¼ 0.46) and tongue (R2 ¼ 0.10). The lower performance in lip and in particular tongue was mainly
attributed to the more layered anatomical structure, which influences scattering properties and photosensitizer dis-
tribution. © 2012 Society of Photo-Optical Instrumentation Engineers (SPIE). [DOI: 10.1117/1.JBO.17.6.067001]
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1 Introduction
Photodynamic therapy (PDT) has been established as a local
treatment modality for several kinds of malignancies in various
organs.1–7 PDT is based on the use of a light sensitive drug, a
photosensitizer, which is locally applied or systemically admi-
nistered. The photosensitizer meta-tetra(hydroxyphenyl)chlorin
(mTHPC or Temoporfin) is one of the most potent clinically
used photosensitizers to date.8–10 Its development, study and
clinical use was recently summarized in a comprehensive
review.11 The formulation of mTHPC in ethanol and propylene
glycol, Foscan®, is in use for both curative and palliative treat-
ment of head and neck squamous cell carcinoma (SCC).7,12 The
treatment involves excitation of the administered photosensitizer
with non-thermal light at the tumor site, which leads to the for-
mation of cytotoxic reactive oxygen species.9,13–17 The amount
of reactive oxygen species formed depends on the type of photo-
sensitizer, its concentration, tissue oxygenation, and the rate of
irradiation. In head & neck tumors, treatment is typically per-
formed using a mTHPC dose of 0.15 mg kg−1 and light fluence
of 20 J cm−2 at a fluence rate of 100 mWcm−2 delivered at
652 nm.11 However, despite the fixed light fluence and adminis-
tered drug dose differences in PDT response may occur. Mon-
itoring PDT parameters such as oxygenation, light fluence, and
photosensitizer concentration during therapy could provide
insight in the complex and dynamic interactions that occur
during PDT and could give information on the deposited
PDT dose.18 Our group recently developed fluorescence differ-
ential path-length spectroscopy (FDPS) as a tool to quantify
photosensitizer concentration and micro vascular oxygen satura-
tion, a surrogate marker of tissue oxygen concentration.19,20 In
previous research, we were able to show that FDPS can be used
to measure photosensitizer concentration in vivo in rat liver.21
In this proof-of-concept study, our group used Foscan at
0.3 mg kg−1 as the target photosensitizer. A good linear correla-
tion was found between the mTHPC concentration measured
with FDPS and the mTHPC concentration measured by chemi-
cal extraction. As a next step towards clinical translation of
FDPS for monitoring PDT in head and neck tumors, we here
evaluate the performance of FDPS using a clinically relevant
drug dose of 0.15 mg kg−1 in target organs for head-and-neck
PDT: the lip and the tongue. From a tissue optics point of
view it is more challenging to analyze oral mucosal tissues com-
pared to liver tissue. For example, oral tissues such as the dor-
sum of the tongue and palate are keratinized and are effectively
layered media, while the inner lip and floor of the mouth are less
so. The keratinisation of the dorsal tongue is present in all mam-
mals, although the degree of keratinisation varies among spe-
cies.22 In the present study, we have investigated how
accurately FDPS measures photosensitizer concentrations in
these more optically heterogeneous media. Similar to our pre-
vious proof-of-concept study, chemical extraction will serve as
the gold standard for mTHPC concentration in these tissues.
One of the problems of Foscan in pre-clinical and clinical
PDT is its poor water solubility, which results in aggrega-
tion.11,23 Therefore, water soluble liposomal formulations haveAddress all correspondence to: Sebastiaan A. H. J. de Visscher, University Med-
ical Center Groningen, Department of Oral and Maxillofacial Surgery, Room
S3.214, Hanzeplein 1, P.O. Box 30.001, 9700 RB Groningen, The Netherlands.
Tel: +31 50 361 3846; Fax: +31 50 361 1136; E-mail: s.a.h.j.de.visscher@umcg.nl 0091-3286/2012/$25.00 © 2012 SPIE
Journal of Biomedical Optics 067001-1 June 2012 • Vol. 17(6)
Journal of Biomedical Optics 17(6), 067001 (June 2012)
Downloaded From: https://www.spiedigitallibrary.org/journals/Journal-of-Biomedical-Optics on 1/8/2019
Terms of Use: https://www.spiedigitallibrary.org/terms-of-use
been designed as nanocarriers for mTHPC. A further advantage
of liposomal drug-carrier systems is a reduced uptake by the
reticuloendothelial system (RES) and an enhanced permeability
and retention effect (EPR).24 Two liposomal mTHPC formula-
tions that have been developed are Foslip® and Fospeg®.8,25–32
In Fospeg, the surfaces of the liposomes are coated by a hydro-
philic polymer to further decrease recognition by the RES
and thus increase circulation time over Foscan and Foslip.24,33
Both the incorporation of mTHPC into liposomes and the
composition of different liposomes are known to significantly
influence the spectral properties.28,30 Furthermore, Foslip and
Fospeg are known to exhibit different redistribution patterns
and liposomal stability in serum.30 We have therefore also
investigated the influence of these nanocarriers on FDPS
performance.
2 Material and Methods
2.1 Animal and Procedures
Fifty-four male Wistar rats (HsdCpb:W) weighing between
250 and 350 g, were purchased from Harlan Netherlands
B.V. (Horst, The Netherlands). Three different formulations
of mTHPC were kindly provided by Biolitec AG (Jena,
Germany); Foscan® (4 mgmL−1 mTHPC), Fospeg®
(1.5 mgmL−1 mTHPC) and Foslip® (1.38 mgmL−1 mTHPC).
Prior to the experiment, Foscan, Foslip and Fospeg were dis-
solved for intravenous injection under minimal light and kept
at 4 °C in the dark, as recommended by the manufacturer.
The dosage used was 0.15 mg kg−1 mTHPC and animals
were kept under reduced light conditions (<60 lux). Prior to
the experimental measurements the rats were anaesthetized
using Isoflurane®/O2∕N2O as a general inhalation anesthetic.
Variations in mTHPC concentrations are achieved by taking
measurements at different time points in the pharmacokinetics
profile of each formulation. At 2, 4, 8, 24, 48, or 96 h after injec-
tion (n ¼ 3 animals per formulation per time point) tissue con-
centrations of mTHPC were measured using FDPS. In the oral
cavity, four measurements were performed on the mucosa of the
lip and six on the dorsum of the tongue, all at randomly chosen
locations. Next, tissue overlying the liver was dissected which
allowed measurements at six randomly chosen locations on the
liver. Directly after the optical measurements the animals were
terminated by cervical dislocation. Lip, tongue and liver were
immediately excised and snap-frozen in liquid nitrogen.
FDPS measured the concentration of mTHPC in lip, tongue
and liver based on the emitted fluorescence of mTHPC. The
concentration estimates determined by FDPS were compared
to the concentration determined by chemical extraction. The
experimental design for this study was approved by the experi-
mental welfare committee of the University Medical Center
Groningen and conformed to Dutch and European regulations
for animal experimentation.
2.2 Measurement of mTHPC Tissue Concentration
using FDPS
The measurement setup used, shown in Fig. 1, was based on the
setup described by the group of Amelink et al.19,21 In short,
the measurement probe contained two 800 μm fibers at a
core-to-core distance of 880 μm. The surface of the probe
was polished under an angle of 15 deg to minimize specular
reflections during the measurements. One 800 μm fiber, the
delivery-and-collection fiber (dc), is coupled to a bifurcated
400 μm fiber, containing a “delivery” and a “collection” leg.
The delivery leg is coupled to a 200 μm bifurcated fiber, one
leg of which is connected to a xenon light source (HPX-
2000, Ocean Optics, Duiven, The Netherlands) and the other
leg is connected to a 405 nm diode laser (Power Technology
Inc., Arkansas, USA). The collection leg is coupled to another
bifurcated 200 μm fiber, of which one leg directly leads to the
first channel of spectrograph setup (MC-2000-4-TR2, Ocean
Optics, Duiven, The Netherlands), while the other leg leads
to a 570 nm long-pass filter before leading into the second
channel of the spectrograph. The second 800 μm fiber of the
probe, the collection fiber (c), is coupled to a bifurcated
400 μm fiber. One leg is directly coupled to the third channel
of the spectrograph, while the other leg leads to the 570 nm
long-pass filter, before being coupled in to the fourth channel
of the spectrograph.
Before every measurement, the FDPS system was calibrated
as described previously.7,19 The measured DPS spectra were
fitted to a model extensively described by our group in the
literature,20,21,34–36 which returned quantitative estimates of
blood volume fraction, micro-vascular blood oxygenation,
and vessel diameter. The measured FDPS spectra are corrected
for the effect of absorption by multiplying it by the ratio of DPS-
signals at the excitation wavelength without and with absorption
present, resulting in absorption-corrected FDPS spectra.37 The
contribution of mTHPC to the spectra was extracted by using
a singular value decomposition (SVD) algorithm38,39 using auto-
fluorescence, Protoporphyrin IX (PpIX), and mTHPC fluores-
cence as basis spectra.
2.3 Measurement of mTHPC Tissue Concentration
using Chemical Extraction
To determine the concentration of mTHPC in the excised frozen
tissues, the chemical extraction method of Kascakova was
used40 on small tissue samples (∼0.1 g) of lip, dorsum of the
tongue, and liver. In liver it was possible to randomly obtain
three samples of liver tissue per animal, representative of tissue
located on the liver surface as measured by FDPS. This way, we
could average multiple random locations in both optical and
chemical concentrations measurements of the liver. In tongue
and lip however, we could only obtain one macroscopically
representative tissue sample as measured by FDPS, due to
the small size of the lip and tongue of rats. All tissue samples
obtained were dissolved in 2 mL of the tissue solvent Solva-
ble™ (Perkin Elmer, Groningen, The Netherlands) over 2 h
at 50°C with regular stirring. Subsequently, the solubilised solu-
tion was diluted further with Solvable™ to an optical density
(OD) <0.1. The diluted samples were analyzed in a fluorimeter
(Perkin Elmer, Groningen, The Netherlands) by using an exci-
tation wavelength of 423 nm and a spectral detection band of
450 to 800 nm with a resolution of 0.5 nm. The basis spectrum
of mTHPCwas derived after correction for Solvable™ and auto-
fluorescence components. The concentration of mTHPC was
derived from a known calibration curve.40
2.4 Statistics and Correlation
Confidence intervals on the individual parameters for the indi-
vidual measurements were determined based on the covariance
matrix generated for each fit as described by Amelink et al.41
Differences in fluorescence intensities between formulations
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and tissue types at similar time points, were determined using
one-way ANOVA (two-tailed) with the Bonferroni test for
selected pairs of columns. Non-linear regression was used to
fit a straight line forced through the origin to characterize the
relation between FDPS and chemical extraction for different
locations and formulations. To quantify goodness of fit of the
regression lines, R2 values and 95% confidence intervals (CI)
were determined.
Differences in slope of regression lines between datasets
were assessed by the sum-of-squares F-test using a confidence
interval of p ¼ 0.05. Pearson’s correlation coefficient was used
(two-tailed, 95% CI) in determining the correlation coefficients
(r) between mTHPC fluorescence (FDPS) and blood volume
(DPS). Graphpad Prism® (v5.0) was used for all statistical
analysis.
2.5 Confocal Fluorescence Microscopy
Frozen tissue samples of control and mTHPC administered
animals were handled under subdued light conditions. Liver,
tongue and lip tissue sections of 50 μm were cut and mounted
on Starfrost® adhesive glass slides (Menzel, Braunschwig,
Germany). Fluorescence images were acquired at 10× magnifi-
cation using a confocal fluorescence microscope (LSM510,
Zeiss, Jena, Germany). Excitation and light collection was per-
formed using a 405 nm laser equipped with a 505 nm long-pass
detection filter combined with spectral detection between 545
and 706 nm at 10 nm intervals. Typically 5 μm optical slices
were acquired from the center of each 50 μm section. Software
written in LabVIEW (v7.1) was used to account for the auto-
fluorescence component of the raw fluorescence; the intensity
of resulting images was confirmed to be that attributable to
mTHPC fluorescence.
3 Results
Typical DPS and FDPS spectra and their fits are shown in
Fig. 1(a) and 1(b), respectively. The fitted mTHPC contributions
of all 54 rats in the lip, tongue and liver at different time points
based on the FDPS measurements are shown in Fig. 2(a). The
actual mTHPC concentrations determined using chemical
extraction are shown in Fig. 2(b).
3.1 Comparison of FDPS Versus Extraction
A global comparison of the FDPS and extraction graphs per
tissue type in Fig. 2(a) and 2(b), shows a similar trend for
both methods as a function of time. One noticeable difference
is that FDPS clearly measures more mTHPC in the lip than
in the tongue at all time points, whereas the mTHPC con-
centrations from extraction in these tissue types appear to be
very similar. A comparison of mean fluorescence measured
by extraction shows no difference (p > 0.05) between lip
and tongue tissue. However, the same comparison in fluores-
cence signal measured by FDPS in Fig. 2(a) shows a signifi-
cantly (p < 0.0001) higher intensity fluorescence in the lip.
To further investigate this issue, we plotted the mTHPC com-
ponent of the FDPS fluorescence versus the mTHPC concentra-
tion measured by chemical extraction for each formulation and
tissue location within the same rat, as shown in Fig. 3, thereby
correcting for possible inter-animal differences in mTHPC
uptake and intravenous administration. A linear regression
line forced through the origin was used to characterize the rela-
tion between FDPS and chemical extraction for different
locations and formulations.
In liver tissue, an excellent goodness of fit was found for
Foscan, Foslip and Fospeg, as shown in Fig. 3(a). The six regres-
sion lines for lip and tongue tissues in Fig. 3(b) and 3(c) showed
overall much lower R2, except for Foslip in lip tissue. Pooling of
data per tissue-type without discriminating for formulation-type,
pictured in Fig. 3(d), clearly showed differences in goodness of
fit between different tissue types. In the liver an excellent good-
ness of fit (R2 of 0.79) was observed, while in lip (R2 ¼ 0.46)
and in particular in tongue (R2 ¼ 0.10), goodness of fit was
much lower.
Fig. 1 Schematic diagram of the FDPS measurement setup used in our study. On the right, acquired representative paired DPS spectra and fits (a) and
FDPS spectra and fits (b) from the rat lip are shown. The fluorescence spectra demonstrate both autofluorescence and fluorescence attributable
to mTHPC.
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3.2 Influence of mTHPC Formulations and
Tissue Type
The influence of mTHPC formulation on FDPS was investi-
gated by assessing differences in slope of regression lines within
each tissue type. The sum-of-squares F-test showed a significant
(p < 0.05, F: 3.252) difference in slope between mTHPC formu-
lations in the liver, with Fospeg showing the highest slope in
Fig. 3(a). Similar analysis in lip and tongue tissue, showed
no significant (p < 0.05) difference in slope between the formu-
lations. Therefore, it is possible to calculate one slope for all
three formulations in tongue and lip tissue in Fig. 3(d). In lip
and tongue tissue, the goodness of fit to the shared regression
line (lip: y ¼ 388.6x, 95% CI: 321.1 to 456.2, tongue:
y ¼ 98.85x, 95% CI: 80.85 to 116.9) remained similar com-
pared to the fit to 3 individual lines. In order to assess the influ-
ence of tissue type on the slope regression lines, one overall
regression line for liver was computed as well (y ¼ 258.4x,
95% CI: 242.8 to 280.5). The differences in slope of the overall
regression lines of liver, lip and tongue are clear in Fig. 3(d).
Further statistical analysis confirmed the difference visually
observed between the regression slopes of lip, tongue and
liver: p < 0.001, F: 15.70.
To elucidate the differences between the slopes of the regres-
sion lines observed for different tissue types, the DPS data were
further analyzed for scattering and blood volume fraction differ-
ences. Overall analysis of the scattering amplitude per tissue
type, shown in Table 1, shows significant differences between
tissue types (p < 0.05), with the least amount of scattering mea-
sured in the liver. No significant difference between the scatter-
ing amplitude for different mTHPC formulations was found at
any time point in any tissue location. The blood volume fraction
was found to have a significant correlation with mTHPC fluor-
escence only in the liver at the early (2, 4, and 8 h) time points; a
significant Pearson’s correlation (r) was found with values of
0.90, 0.57, and 0.82, respectively.
Fig. 2 mTHPC concentration vs. time measured by FDPS (a) and chemical extraction (b) in lip, tongue, and liver tissue for Foscan, Foslip, and Fospeg
(error bars indicate SEM). Note the logarithmic scale used for the y-axes
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3.3 Confocal Microscopy
To further investigate our findings of a lower correlation
between FDPS and chemically extracted samples in lip and
tongue versus liver, fluorescence microscopy was performed
to determine differences in mTHPC distribution among tissues.
Confocal fluorescence microscopy was performed on 50 μm
sections of liver, tongue and lip at various time points. Typical
examples are shown in Fig. 4. Differences between tissue types
are clearly observable; mTHPC is homogeneously spread
throughout the liver section, while in lip and especially tongue
tissue mTHPC is more heterogeneously distributed. Further-
more, the presence of layered structures can be clearly
seen on the transmission images in lip and especially the tongue.
In tongue tissue, the filliform papillae can be clearly seen, and
these structures do not contain any mTHPC. In lip tissue, a much
smaller superficial layer shows no uptake of mTHPC, while an
increased uptake is seen in the basement membrane.
4 Discussion
The relationship between mTHPC concentration and therapeutic
outcome is complicated as numerous parameters influence
the deposited PDT dose. However, the amount of mTHPC
present in tissue is clearly an important factor in the PDT
dosage. Non-invasive monitoring of mTHPC concentration,
as well as other important parameters during PDT, could allow
for standardization and optimization of clinical PDT.4,18,42,43
The aim of this study was to test the optical photosensitizer
concentration measurement technique FDPS in a more
clinically relevant environment compared to previous research
performed on liver tissue.21 Therefore, in our present study
we used both clinically relevant tissue locations and a clinically
used drug dose. Furthermore, we tested the influence of
promising new liposomal mTHPC formulations on FDPS
performance.
In the liver, linear regression analysis showed an excellent
goodness of fit (R2) for the FDPS data to the extraction data,
with Foscan, Foslip, and Fospeg showing similar R2. As a
further validation for FDPS with our lower drug dose we com-
pared our R2 to the results of Kruijt et al.21 They found a R2
value of 0.87 for Foscan measured by FDPS in the liver; we
found a slightly lower R2 value of 0.74. Our R2 values were
higher for Fospeg and Foslip at 0.82 and 0.89 respectively.
Therefore, our measurements indicate that FDPS results could
be reproduced in the liver at the clinically relevant dose of
0.15 mg∕kg mTHPC, and extended to the Foslip and Fospeg
formulations. Note that although the R2 values can be compared
Fig. 3 Optically measured mTHPC concentration (FDPS) versus true mTHPC concentration (extraction) for 3 different mTHPC formulations (Foscan,
Foslip, Fospeg) in lip (a), liver (b), and tongue (c) tissue (error bars indicate SD, logarithmic scales). One measurement point represents multiple FDPS
and extraction measurements of 1 rat. Best fit linear regression lines forced through the origin are plotted as solid lines. Pooled data per tissue type
(d) show significant differences (p < 0.001) in the slopes of the regression lines between the tissue types (linear scales). In (d), for clarity purposes only a
portion of the data are shown and error bars are omitted.
Table 1 Means and standard deviations of Mie scattering amplitudes
in arbitrary units measured by FDPS for different tissue types.
Tongue Liver Lip
Mean 1.220 0.5579 1.722
SD 0.1150 0.01844 0.1839
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between this study and the study of Kruijt et al., the regression
line slopes cannot be compared between these two studies due to
differences in the distance between the probe tip and the cali-
bration standard as well as the difference in excitation wave-
lengths. The shorter wavelength in the current study excites
mTHPC at its maximum absorption peak, to maximize mTHPC
fluorescence at a lower drug dose. Because both the calibration
method and the excitation wavelength were kept constant during
our current study, comparison of regression line slopes within
our study is possible.
FDPS measurements in a clinically relevant and optically
more demanding environment of tongue and lip tissue showed
a lower correlation between the FDPS data and the extraction
data. Especially in tongue tissue, the correlation was poor
with R2 approaching 0 for all formulations. FDPS in lip tissue
performed only slightly better. The possible reasons for this poor
correlation are discussed below.
4.1 Influence of mTHPC Formulation on
FDPS Performance
The influence of mTHPC formulation on FDPS signal proved
to be significant in liver; Fospeg showed a higher slope of the
regression line compared to both Foslip and Foscan. This
suggests Fospeg has a significant higher quantum yield com-
pared to the other formulations in vivo. This could be explained
by a relatively higher amount of non-aggregated mTHPC
molecules in liposomal formulations.24 Other in vivo studies
also describe a higher fluorescence of Fospeg compared to
Foscan,25,26 although in these studies fluorescence intensity is
Fig. 4 Representative confocal fluorescencemicroscopy of tongue (a), liver (b) and lip (c). Images on the left depict distribution of mTHPC (colored red),
corrected for autofluorescence. Images on the right show white light transmission images of the same slide. White scale bar: 500 μm, corresponding
approximately with the interrogation depth of FDPS. The arrow in (a) indicates one of the filliform papillae on the surface of the dorsal tongue.
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also influenced by formulation specific pharmacokinetics such
as aggregation and EPR. The significant difference in slope
between the regression lines of Fospeg and Foslip probably
depends on the detailed characteristics of the liposomes. It is
known that PEGylation of liposomes lengthens the plasma
half-life of liposomes, thereby enabling a longer relative mono-
meric state of mTHPC in Fospeg, and resulting in a relatively
higher slope of the regression line compared to Foslip.
In both tongue and lip tissue, no significant difference in
slope of the regression lines between the three mTHPC formu-
lations was present. However, this may well be related to the
lower goodness of fit and the broader CI of the regression
lines in tongue and lip compared to liver, making a significant
difference difficult to establish.
4.2 Influence of Tissue Type on FDPS Performance
Data analysis in Fig. 3(d) shows very distinct differences in
FDPS performance by both the goodness of fit (R2) and the
slope of the regression lines between tissue types. Fluorescence
microscopy showed clear differences in the tissue-specific dis-
tribution of mTHPC at all time points; in liver, mTHPC was
much more homogeneously distributed compared to both lip
and tongue tissue. Furthermore, in tongue tissue an absence
of mTHPC fluorescence was seen in the most superficial, dorsal
layer around the papillae. In contrast, in lip tissue the distinct
basement membrane close to the surface shows more mTHPC
fluorescence compared to the stroma. Similar to the tongue, the
most superficial layer shows almost no mTHPC fluorescence;
however, in lip tissue this superficial layer of the lip is much
smaller than in tongue tissue. These differences in distribution
of mTHPC can be explained by the known difference in uptake
of the dye in various structures like epithelium, lamina propria,
striated muscle, smooth muscle, glands and fibro-connective
tissue.44–47 While liver tissue consists of multiple similar
lobules, lip and tongue have a more complicated, layered com-
position.
The most important anatomical difference between lip and
tongue tissue is the presence of keratinized stratified mucosa
in the dorsal tongue while the inner side of the lip is covered
by smooth non-keratinized mucosa. Besides tissue specific
differences in mTHPC uptake, the biodistribution of mTHPC
varies greatly with time.46,48 However, the tissue specific
mTHPC distribution is bound to have some influence on optical
concentration measurements.
More challenging for our fluorescence measurement are
the structural differences between tissue types. The layered,
heterogeneous anatomy will certainly influence the tissue
specific optical properties, in particular scattering properties.
This difference is illustrated by significantly higher scattering
amplitudes for lip and tongue tissue compared to liver tissue.
Further indication of heterogeneity of lip and tongue tissue is
given by the overall larger standard deviations of the scattering
amplitude data compared to liver in Table 1.
With knowledge of the microscopic differences observed in
anatomy and mTHPC distribution between tissue types, we can
explain the tissue specific differences in FDPS performance.
The significant difference we found between correlation
coefficients and slopes of the regression lines for different tissue
types is potentially caused by a combination of three factors: 1.
the layered biodistribution of photosensitizer in combination
with the superficial sampling volume of FDPS versus the
larger sampling volume of chemical extraction, 2. inter-animal
variations in the thickness of the keratin layers, and 3. the large
differences in scattering properties between tissue types.
Although FDPS yields absorption-corrected data, it does not
correct for inter- and intra-tissue scattering differences.19,21,37
As a result, the slope of the correlation between FDPS
and extraction will be influenced by the average scattering
coefficient of the tissue under investigation. Table 1 shows
that the scattering properties vary with tissue type, resulting
in different correlation slopes; furthermore, intra- and inter-
animal variations in scattering properties are more pronounced
in more heterogeneous, layered tissues, such as tongue, resulting
in a poorer correlation. A future challenge in improving optical
concentration measurement performance would therefore be the
ability to correct for scattering.49
With regard to the first two factors, the correlation coeffi-
cients and slopes of the regression lines are also affected by
a difference in interrogation volume of both techniques (extrac-
tion and FDPS). The minimum interrogation volume necessary
to obtain accurate extraction data is ∼102 mm3, compared to
∼0.2 mm3 for FDPS. This difference will influence the slope
of the regression line in tissue with a relatively heterogeneous,
layered mTHPC distribution, as found in tongue and lip tissue.
In tongue a large part of the FDPS interrogation volume
∼500 μm of the dorsal tongue consists of filliform papillae,
as seen in Fig. 4. Papillae in the rat can be up to 200 μm in
length50 and showed decreased mTHPC uptake. Therefore
only roughly half the FDPS interrogation volume contains
mTHPC, resulting in a lower slope of the regression line
between FDPS-extracted mTHPC concentration and chemical
extraction in the tongue. Conversely, because the surface of
the lip tissue has an increased uptake of mTHPC compared
to the surface of the tongue, the FDPS-measured mTHPC fluor-
escence in the lip increases for the same chemically extracted
mTHPC concentration. This explains the significant higher
mTHPC fluorescence as measured by FDPS in lip compared
to tongue tissue, whereas in the extraction the mTHPC concen-
trations in these tissue types appear to be very similar. Further-
more, a lower correlation will be found for tissues with more
heterogeneous photosensitizer distributions. Although multiple
FDPS measurements are averaged for each animal on each tis-
sue type, inter-animal variations in photosensitizer biodistribu-
tion with tissue depth will not be averaged out and result in poor
correlations. Similarly, inter-animal variations in average keratin
layer thickness will also result in poor correlations between the
superficially localized FDPS measurement and the “bulk” che-
mical extraction. The average thickness of the keratin layer in
the Wistar rat tongue is described by others as 150 μm
(SD 100), measured at a central portion of the dorsal tongue.51
However, the highly keratinized filliform papillae are well
known to have substantial, intra-animal morphological variation
among differing sites of the dorsal rat tongue.50 This is sup-
ported by the even higher variation in average thickness we
found for the whole dorsal tongue; 200 μm (SD 120).
Extrapolation of our current results to the clinic is difficult;
the dimensions and anatomy in normal human tissue are differ-
ent compared to that of a rat.52 For example, in humans the ker-
atin layer of normal tissues is on average much smaller than in a
rat, which is likely to pose less of a problem for the application
of our technique on human tongue.22,52 Furthermore, the phar-
macokinetics of mTHPC differs between humans and rodents.23
Another complicating factor is significant spatial variation in
mTHPC biodistribution within tumors.48 Moreover, tumors of
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the oral cavity could also disrupt or change the keratin layer,
and therefore influence the performance of our technique. All
these aspects may lead to very different observations and
very different levels of homogeneity and heterogeneity in
human healthy and tumor tissues. In our current pre-clinical
study, the emphasis has been on careful investigation of quan-
titative mTHPCmeasurements in optically more challenging tis-
sues and of the influence of liposomal formulations. Promising
nonetheless were the results of a recent clinical study using
FDPS in humans.37 The feasibility of clinical FDPS was
shown, as clinical PDT treatments were monitored in three
patients with SCCs of the oral cavity.
5 Conclusion
The non-invasive optical technique FDPS shows promising
results in determining the mTHPC concentration in the rat
liver for Foscan and for both liposomal formulations; Foslip
and Fospeg. In liver, Fospeg showed a significant higher quan-
tum yield compared to the other formulations. In optically
homogeneous liver, the correlation with the chemical extraction
data was excellent. In the more heterogeneous lip tissue the cor-
relation was lower. In tongue tissue the correlation was poor.
The most likely causes of these differences in correlation are
the more demanding optical characteristics of lip and especially
tongue tissue. In tongue tissue, FDPS performance is even
further decreased by a thick layer of keratinized epithelium,
which influences the optically sampled mTHPC distribution.
Furthermore, in order to accurately monitor mTHPC concentra-
tion in heterogeneous tissue, a correction for scattering is
needed. This is particularly important for future monitoring
of mTHPC in spatially heterogeneous tumor tissues.
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